Get the Stockscreener App
1.098
1.08%
-0.012
Biorestorative Therapies Inc stock is traded at $1.098, with a volume of 60,087.
It is down -1.08% in the last 24 hours and down -30.94% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.11
Open:
$1.1
24h Volume:
60,087
Relative Volume:
0.37
Market Cap:
$9.75M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-0.8074
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
-17.44%
1M Performance:
-30.94%
6M Performance:
-29.16%
1Y Performance:
-24.01%
1-Day Range:
$1.04
$1.1099
1-Week Range:
$1.04
$1.4496
52-Week Range:
$1.04
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.098 | 9.85M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Can BioRestorative Therapies Inc. stock sustain revenue growth2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
What momentum indicators show for BioRestorative Therapies Inc. stock2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
How BioRestorative Therapies Inc. (9OF) stock reacts to monetary easingEarnings Risk Summary & Low Drawdown Trading Strategies - newser.com
Is BioRestorative Therapies Inc. (9OF) stock a buy on weaknessStock Surge & Expert Curated Trade Setups - newser.com
Will BioRestorative Therapies Inc. stock return to pre crisis levelsWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Identifying reversal signals in BioRestorative Therapies Inc.2025 Investor Takeaways & Daily Price Action Insights - newser.com
Real time pattern detection on BioRestorative Therapies Inc. stockWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - newser.com
How BioRestorative Therapies Inc. (9OF) stock reacts to fiscal policiesEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Published on: 2025-11-19 05:25:14 - newser.com
Why BioRestorative Therapies Inc. stock is recommended by analystsWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Chart overlay techniques for tracking BioRestorative Therapies Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
What technical signals suggest for BioRestorative Therapies Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - newser.com
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Up 6.4% – What’s Next? - Defense World
Equities Analysts Offer Predictions for BRTX FY2025 Earnings - Defense World
BioRestorative Therapies, Inc. Secures Type B Meeting with FDA for Potential Accelerated BLA Approval of BRTX-100 for Chronic Lumbar Disc Disease - Quiver Quantitative
BioRestorative (NASDAQ: BRTX) to Discuss Accelerated BLA Path for BRTX-100 cLDD - Stock Titan
BioRestorative Therapies (BRTX) Price Target Increased by 62.50% to 13.26 - Nasdaq
Published on: 2025-11-16 17:25:49 - newser.com
Will BioRestorative Therapies Inc. stock gain from lower inflationWatch List & Weekly Momentum Picks - newser.com
Using R and stats models for BioRestorative Therapies Inc. forecasting2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com
BioRestorative Therapies Inc. stock chart pattern explainedBear Alert & Low Risk High Reward Trade Ideas - newser.com
Is BioRestorative Therapies Inc. stock undervalued vs historical averagesMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Will earnings trigger a reversal in BioRestorative Therapies Inc.2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
How currency fluctuations impact BioRestorative Therapies Inc. stockVolume Spike & Daily Growth Stock Tips - newser.com
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q3 2025 Earnings Call Transcript - Insider Monkey
Applying Wyckoff theory to BioRestorative Therapies Inc. stockMarket Performance Summary & Advanced Technical Signal Analysis - newser.com
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):